Photosensitizer Spatial Heterogeneity and Its Impact on Personalized Interstitial Photodynamic Therapy Treatment Planning

Overview

Journal J Biomed Opt

Date 2025 Jan 13

PMID 39802351

Authors

Tina Saeidi

Shuran Wang

Hector A Contreras

Michael J Daly

Vaughn Betz

Lothar Lilge

Affiliations

Soon will be listed here.

Abstract

Significance: Personalized photodynamic therapy (PDT) treatment planning requires knowledge of the spatial and temporal co-localization of photons, photosensitizers (PSs), and oxygen. The inter- and intra-subject variability in the photosensitizer concentration can lead to suboptimal outcomes using standard treatment plans.

Aim: We aim to quantify the PS spatial variation in tumors and its effect on PDT treatment planning solutions.

Approach: The spatial variability of two PSs is imaged at various spatial resolutions for an orthotopic rat glioma model and applied to human glioblastoma models to determine the spatial PDT dose, including in organs at risk. An open-source interstitial photodynamic therapy (iPDT) planning tool is applied to these models, deriving the spatial photosensitizer quantification resolution that consistently impacts iPDT source placement and power allocation.

Results: The studies revealed a bimodal photosensitizer distribution in the tumor. The concentration of the PS can vary by a factor of 2 between the tumor core and rim, with slight variation within the core but a factor of 5 in the rim. An average sampling volume of for photosensitizer quantification will result in significantly different iPDT planning solutions for each case.

Conclusions: Assuming homogeneous photosensitizer distribution results in suboptimal therapeutic outcomes, we highlight the need to predict the photosensitizer distribution before source placement for effective treatment plans.

References

Castano A, Demidova T, Hamblin M . Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis Photodyn Ther. 2014; 2(2):91-106. PMC: 4108218. DOI: 10.1016/S1572-1000(05)00060-8. View

MacLaughlin C, Ding L, Jin C, Cao P, Siddiqui I, Hwang D . Porphysome nanoparticles for enhanced photothermal therapy in a patient-derived orthotopic pancreas xenograft cancer model: a pilot study. J Biomed Opt. 2016; 21(8):84002. DOI: 10.1117/1.JBO.21.8.084002. View

Jacques S . Optical properties of biological tissues: a review. Phys Med Biol. 2013; 58(11):R37-61. DOI: 10.1088/0031-9155/58/11/R37. View

Guidolin K, Ding L, Chen J, Wilson B, Zheng G . Porphyrin-lipid nanovesicles (Porphysomes) are effective photosensitizers for photodynamic therapy. Nanophotonics. 2022; 10(12):3161-3168. PMC: 9646248. DOI: 10.1515/nanoph-2021-0220. View

Won N, Bartling M, La Macchia J, Markevich S, Holtshousen S, Jagota A . Deep learning-enabled fluorescence imaging for surgical guidance: training for oral cancer depth quantification. J Biomed Opt. 2024; 30(Suppl 1):S13706. PMC: 11408754. DOI: 10.1117/1.JBO.30.S1.S13706. View

Shattuck D, Leahy R . BrainSuite: an automated cortical surface identification tool. Med Image Anal. 2002; 6(2):129-42. DOI: 10.1016/s1361-8415(02)00054-3. View

Davidson S, Weersink R, Haider M, Gertner M, Bogaards A, Giewercer D . Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol. 2009; 54(8):2293-313. DOI: 10.1088/0031-9155/54/8/003. View

Valdes P, Leblond F, Kim A, Harris B, Wilson B, Fan X . Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg. 2011; 115(1):11-7. PMC: 3129387. DOI: 10.3171/2011.2.JNS101451. View

Collins D, Zijdenbos A, Kollokian V, Sled J, Kabani N, Holmes C . Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging. 1998; 17(3):463-8. DOI: 10.1109/42.712135. View

10.

Tammela T, Sage J . Investigating Tumor Heterogeneity in Mouse Models. Annu Rev Cancer Biol. 2021; 4(1):99-119. PMC: 8218894. DOI: 10.1146/annurev-cancerbio-030419-033413. View

11.

Yassine A, Lilge L, Betz V . Machine learning for real-time optical property recovery in interstitial photodynamic therapy: a stimulation-based study. Biomed Opt Express. 2021; 12(9):5401-5422. PMC: 8515975. DOI: 10.1364/BOE.431310. View

12.

Jankun J, Lilge L, Douplik A, Keck R, Pestka M, Szkudlarek M . Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy. J Urol. 2004; 172(2):739-43. DOI: 10.1097/01.ju.0000135304.96496.20. View

13.

Clement S, Anwer A, Pires L, Campbell J, Wilson B, Goldys E . Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles. Int J Mol Sci. 2021; 22(12). PMC: 8232618. DOI: 10.3390/ijms22126425. View

14.

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P . The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013; 26(6):1045-57. PMC: 3824915. DOI: 10.1007/s10278-013-9622-7. View

15.

Trachtenberg J, Weersink R, Davidson S, Haider M, Bogaards A, Gertner M . Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int. 2008; 102(5):556-62. DOI: 10.1111/j.1464-410X.2008.07753.x. View

16.

Davnall F, Yip C, Ljungqvist G, Selmi M, Ng F, Sanghera B . Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?. Insights Imaging. 2012; 3(6):573-89. PMC: 3505569. DOI: 10.1007/s13244-012-0196-6. View

17.

Pogue B, Burke G . Fiber-optic bundle design for quantitative fluorescence measurement from tissue. Appl Opt. 2008; 37(31):7429-36. DOI: 10.1364/ao.37.007429. View

18.

Yaroslavsky A, Schulze P, Yaroslavsky I, SCHOBER R, Ulrich F, Schwarzmaier H . Optical properties of selected native and coagulated human brain tissues in vitro in the visible and near infrared spectral range. Phys Med Biol. 2002; 47(12):2059-73. DOI: 10.1088/0031-9155/47/12/305. View

19.

Yassine A, Kingsford W, Xu Y, Cassidy J, Lilge L, Betz V . Automatic interstitial photodynamic therapy planning via convex optimization. Biomed Opt Express. 2018; 9(2):898-920. PMC: 5854086. DOI: 10.1364/BOE.9.000898. View

20.

Chang E, Bu J, Ding L, Lou J, Valic M, Cheng M . Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy. J Nanobiotechnology. 2021; 19(1):154. PMC: 8147067. DOI: 10.1186/s12951-021-00898-1. View